400 related articles for article (PubMed ID: 22512680)
1. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.
Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():47-51. PubMed ID: 22512680
[TBL] [Abstract][Full Text] [Related]
2. Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities.
Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():36-46. PubMed ID: 22512679
[TBL] [Abstract][Full Text] [Related]
3. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children.
Boner AL
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S32-9. PubMed ID: 11449204
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature.
Chrousos GP; Harris AG
Neuroimmunomodulation; 1998; 5(6):288-308. PubMed ID: 9762011
[TBL] [Abstract][Full Text] [Related]
5. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression.
Levin E; Gupta R; Butler D; Chiang C; Koo JY
J Dermatolog Treat; 2014 Dec; 25(6):501-6. PubMed ID: 24171390
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
[TBL] [Abstract][Full Text] [Related]
7. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
Andres P; Poncet M; Farzaneh S; Soto P
J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
[TBL] [Abstract][Full Text] [Related]
8. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)--the risk as determined by gold standard adrenal function tests: a systematic review.
Zöllner EW
Pediatr Allergy Immunol; 2007 Sep; 18(6):469-74. PubMed ID: 17680905
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Hypothalamic-Pituitary-Adrenal Axis Suppression following Cutaneous Use of Topical Corticosteroids in Children: A Meta-Analysis.
Wood Heickman LK; Davallow Ghajar L; Conaway M; Rogol AD
Horm Res Paediatr; 2018; 89(6):389-396. PubMed ID: 29898449
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients.
Besemer F; Kramers C; Brinkman K; Hermus ARMM; van Herwaarden AE; Burger DM
Int J Clin Pharm; 2020 Apr; 42(2):347-350. PubMed ID: 32140912
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
Bernstein DI; Allen DB
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
[TBL] [Abstract][Full Text] [Related]
13. Screening for hypothalamo-pituitary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids.
Brown PH; Blundell G; Greening AP; Crompton GK
Respir Med; 1991 Nov; 85(6):511-6. PubMed ID: 1775678
[TBL] [Abstract][Full Text] [Related]
14. Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis.
Saleem MD; Feldman SR
J Dermatolog Treat; 2018 Feb; 29(1):36-38. PubMed ID: 28494626
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
16. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
[TBL] [Abstract][Full Text] [Related]
17. Oral corticosteroids for asthma exacerbations might be associated with adrenal suppression: Are physicians aware of that?
Barra CB; Fontes MJF; Cintra MTG; Cruz RC; Rocha JAG; Guimarães MCC; Silva IN
Rev Assoc Med Bras (1992); 2017 Oct; 63(10):899-903. PubMed ID: 29267492
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of inhaled corticosteroids and HPA axis suppression.
Dluhy RG
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S447-50. PubMed ID: 9563370
[TBL] [Abstract][Full Text] [Related]
19. Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study.
Smy L; Shaw K; Amstutz U; Smith A; Berger H; Carleton B; Koren G
BMC Pregnancy Childbirth; 2016 Jul; 16(1):176. PubMed ID: 27440139
[TBL] [Abstract][Full Text] [Related]
20. Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function, part I: general overview of HPA axis study design.
Fan Y; Ma L; Pippins J; Limb S; Xu Y; Sahajwalla CG
J Pharm Sci; 2013 Oct; 102(10):3513-27. PubMed ID: 23918409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
